7 February 2024 false No description of principal activity Taxfiler 2024.6 true NI709764 business:PrivateLimitedCompanyLtd 2024-02-07 2025-02-28 NI709764 2024-02-06 NI709764 2024-02-07 2025-02-28 NI709764 business:AuditExemptWithAccountantsReport 2024-02-07 2025-02-28 NI709764 business:FilletedAccounts 2024-02-07 2025-02-28 NI709764 2025-02-28 NI709764 business:Director1 2024-02-07 2025-02-28 NI709764 business:RegisteredOffice 2024-02-07 2025-02-28 NI709764 core:WithinOneYear 2025-02-28 NI709764 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-02-28 NI709764 core:PreviouslyStatedAmount 2025-02-28 NI709764 business:SmallEntities 2024-02-07 2025-02-28 NI709764 countries:NorthernIreland 2024-02-07 2025-02-28 iso4217:GBP xbrli:pure
Company Registration No. NI709764 (Northern Ireland)
Aestheticrx Medical Aesthetics Limited Unaudited accounts for the period from 7 February 2024 to 28 February 2025
Aestheticrx Medical Aesthetics Limited Unaudited accounts Contents
Page
Company information
3
Accountants' report
4
Statement of financial position
5
Notes to the accounts
6
- 2 -
Aestheticrx Medical Aesthetics Limited Company Information for the period from 7 February 2024 to 28 February 2025
Director
William Lewis Clotworthy
Company Number
NI709764 (Northern Ireland)
Registered Office
27 Templemoyle Kells Ballymena County Antrim BT42 3LG Northern Ireland
Accountants
DJB Accounting Ltd 34 Knockmoyle Drive Greystone Road Antrim BT41 1HE
- 3 -
Aestheticrx Medical Aesthetics Limited Accountants' report
Accountants' report to the director of Aestheticrx Medical Aesthetics Limited on the preparation of the unaudited statutory accounts for the period from 7 February 2024 to 28 February 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Aestheticrx Medical Aesthetics Limited for the period from 7 February 2024 to 28 February 2025 as set out on pages 5 - 6 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Aestheticrx Medical Aesthetics Limited, as a body, in accordance with the terms of our engagement letter dated 29 May 2025. Our work has been undertaken solely to prepare for your approval the accounts of Aestheticrx Medical Aesthetics Limited and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Aestheticrx Medical Aesthetics Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Aestheticrx Medical Aesthetics Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Aestheticrx Medical Aesthetics Limited. You consider that Aestheticrx Medical Aesthetics Limited is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the accounts of Aestheticrx Medical Aesthetics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
DJB Accounting Ltd 34 Knockmoyle Drive Greystone Road Antrim BT41 1HE 20 October 2025
- 4 -
Aestheticrx Medical Aesthetics Limited Statement of financial position as at 28 February 2025
2025
Notes
£
Current assets
Cash at bank and in hand
1,219
Creditors: amounts falling due within one year
4
(849)
Net current assets
370
Net assets
370
Capital and reserves
Profit and loss account
370
Shareholders' funds
370
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 October 2025 and were signed on its behalf by
William Lewis Clotworthy Director Company Registration No. NI709764
- 5 -
Aestheticrx Medical Aesthetics Limited Notes to the Accounts for the period from 7 February 2024 to 28 February 2025
1
Statutory information
Aestheticrx Medical Aesthetics Limited is a private company, limited by shares, registered in Northern Ireland, registration number NI709764. The registered office is 27 Templemoyle, Kells, Ballymena, County Antrim, BT42 3LG, Northern Ireland.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
4
Creditors: amounts falling due within one year
2025
£
Taxes and social security
212
Loans from directors
205
Accruals
432
849
5
Average number of employees
During the period the average number of employees was 1.
- 6 -